To see the other types of publications on this topic, follow the link: Treatment options.

Journal articles on the topic 'Treatment options'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Treatment options.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Nanjundappaa, Shiva Murthy. "Medical treatment options available for mucormycosis." Journal of Pharmacovigilance and Drug Research 2, no. 4 (2021): 14–21. http://dx.doi.org/10.53411/jpadr.2021.2.4.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Erkinjuntti, Timo. "Treatment options." Journal of the Neurological Sciences 203-204 (November 2002): 125–30. http://dx.doi.org/10.1016/s0022-510x(02)00267-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Steinbeck, Katharine. "Treatment options." Best Practice & Research Clinical Endocrinology & Metabolism 19, no. 3 (2005): 455–69. http://dx.doi.org/10.1016/j.beem.2005.04.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ndukwe, Munachiso Onyedikachi, Ivan Práznovec, Martin Štěpán, Igor Sirák, Aleš Fibír, and Jiří Špaček. "Treatment options for locally recurrent vulvar cancer." Česká gynekologie 86, no. 4 (2021): 246–48. http://dx.doi.org/10.48095/cccg2021246.

Full text
Abstract:
Summary: Objective: Summarizing of treatment options for locally recurrent vulvar cancer in patients after previous complex oncological treatment and presenting a case report from our department. Methods: Presenting a case report of a patient after previous complex oncological treatment for spinocellular cancer of the vulva who presented with a locally recurrent tumor. The patient was treated with a wide radical local excision of the tumor followed by a posterior thigh fl ap graft. Conclusion: Surgical intervention is the primary mode of treatment in locally recurrent cancers of the vulva. Wid
APA, Harvard, Vancouver, ISO, and other styles
5

Capozzi, James D., Rosamond Rhodes, and Darwin Chen. "Discussing Treatment Options." Journal of Bone and Joint Surgery-American Volume 91, no. 3 (2009): 740–42. http://dx.doi.org/10.2106/jbjs.h.01104.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Naclerio. "Optimizing treatment options." Clinical & Experimental Allergy 28, S6 (1998): 54–59. http://dx.doi.org/10.1046/j.1365-2222.1998.0280s6054.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ramasamy, V., A. Williams, R. Pyart, et al. "AKI TREATMENT OPTIONS." Nephrology Dialysis Transplantation 29, suppl 3 (2014): iii1—iii2. http://dx.doi.org/10.1093/ndt/gfu107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pawlik Plank, Darlene M. "Framing Treatment Options." Clinical Nurse Specialist 8, no. 4 (1994): 174–78. http://dx.doi.org/10.1097/00002800-199407000-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Golzarian, Jafar, Earl B. Maes, and Shiliang Sun. "Endoleak: Treatment Options." Techniques in Vascular and Interventional Radiology 8, no. 1 (2005): 41–49. http://dx.doi.org/10.1053/j.tvir.2005.06.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Florczyk, Suzanne, Taiwona Elliott, Kelley Lawrence, Lauren Penwell-Waines, and Cecile Robes. "Headache Treatment Options." Journal of the American Board of Family Medicine 37, no. 4 (2024): 737–44. http://dx.doi.org/10.3122/jabfm.2023.230450r1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Parker, Cindy Schott. "Wound Treatment Options." Home Health Care Management & Practice 10, no. 3 (1998): 30–35. http://dx.doi.org/10.1177/089780189801000306.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Kadir, Rezan A. "Menorrhagia: treatment options." Thrombosis Research 123 (January 2009): S21—S29. http://dx.doi.org/10.1016/s0049-3848(09)70005-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

GILLETT, E. "HYPERLIPID TREATMENT OPTIONS." Clinics in Family Practice 4, no. 3 (2002): 567–83. http://dx.doi.org/10.1016/s1522-5720(02)00017-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Barber, F. Alan. "Meniscal Treatment Options." Sports Medicine and Arthroscopy Review 20, no. 2 (2012): 57. http://dx.doi.org/10.1097/jsa.0b013e31823a011b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Malberti, Fabio. "Hyperphosphataemia: Treatment Options." Drugs 73, no. 7 (2013): 673–88. http://dx.doi.org/10.1007/s40265-013-0054-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Krupa Muniyandi, Divya. "Newer Treatment Options and Ongoing Research in Oncology." Indian Journal of Cancer Education and Research 8, no. 1 (2020): 39–44. http://dx.doi.org/10.21088/ijcer.2321.9815.8120.6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

x, Chetna. "Understanding Migraines: Types, Causes, Symptoms and treatment Options." International Journal of Science and Research (IJSR) 13, no. 8 (2024): 272–73. http://dx.doi.org/10.21275/sr24803220325.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Andersson, K. E. "LUTS treatment: Future treatment options." Neurourology and Urodynamics 26, S6 (2007): 934–47. http://dx.doi.org/10.1002/nau.20500.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Chamberlain, Marc C. "Treatment options for glioblastoma." Neurosurgical Focus 20, no. 4 (2006): E19. http://dx.doi.org/10.3171/foc.2006.20.4.12.

Full text
Abstract:
✓ Following the seminal trial conducted by the European Organisation for Research and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC), concurrent temozolomide and radiotherapy has become the new standard of care for patients with newly diagnosed glioblastoma multiforme (GBM). Investigation of emerging therapies (which are now used as salvage therapy) such as small-molecule inhibitors (for example, epidermal growth factor receptor inhibitors) and convection-enhanced delivery (CED) of targeted toxins (for example, interleukin-13/pseudo-monas exotoxin) is likely to
APA, Harvard, Vancouver, ISO, and other styles
20

Hansen, Frederick, Michael A. Jarvis, Heinz Feldmann, and Kyle Rosenke. "Lassa Virus Treatment Options." Microorganisms 9, no. 4 (2021): 772. http://dx.doi.org/10.3390/microorganisms9040772.

Full text
Abstract:
Lassa fever causes an approximate 5000 to 10,000 deaths annually in West Africa and cases have been imported into Europe and the Americas, challenging public health. Although Lassa virus was first described over 5 decades ago in 1969, no treatments or vaccines have been approved to treat or prevent infection. In this review, we discuss current therapeutics in the development pipeline for the treatment of Lassa fever, focusing on those that have been evaluated in humans or animal models. Several treatments, including the antiviral favipiravir and a human monoclonal antibody cocktail, have shown
APA, Harvard, Vancouver, ISO, and other styles
21

Sivolap, Yu P., and A. A. Portnova. "Anxiety treatment: Updated options." Meditsinskiy sovet = Medical Council, no. 3 (April 12, 2025): 111–16. https://doi.org/10.21518/ms2025-130.

Full text
Abstract:
Generalized anxiety disorder and other anxiety spectrum disorders constitute the category of the most common mental disorders. Three lines of pharmacological therapy are used in the treatment of anxiety disorders: 1) selective serotonin reuptake inhibitors (SSRI) and serotonin and norepinephrine reuptake inhibitors (SNRI); 2) benzodiazepines; 3) antipsychotics. Along with SSRI and SNRI, other groups of antidepressants are used in the treatment of anxiety disorders, and other drugs with anxiolytic properties, such as pregabalin, are being considered as alternatives to benzodiazepines. Drugs in
APA, Harvard, Vancouver, ISO, and other styles
22

Naegel, Steffen, Manjit Matharu, and Mark Obermann. "Treatment Options for Vestibular Migraine." US Neurology 12, no. 01 (2016): 39. http://dx.doi.org/10.17925/usn.2016.12.01.39.

Full text
Abstract:
Although vestibular migraine is a common cause of vertigo, affecting approximately 1% of the Western world’s population, it remains widely under-recognized and is under-diagnosed. Diagnostic criteria for vestibular migraine were recently published in collaboration with the International Headache Society and the Bárány-Society. Trials investigating the treatment of vestibular migraine are sparse but some are now underway. This review focuses on the treatments options available for vestibular migraine, based on the existing evidence base where available. Regarding acute treatments, there are two
APA, Harvard, Vancouver, ISO, and other styles
23

Dunn, Maria L., Elizabeth B. Cockerline, and Mitchell R. Rice. "Treatment Options for Psoriasis." American Journal of Nursing 88, no. 8 (1988): 1081. http://dx.doi.org/10.2307/3470955.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Lopez, Roberto Gabriel L., and Hong-Geun Jung. "Achilles Tendinosis: Treatment Options." Clinics in Orthopedic Surgery 7, no. 1 (2015): 1. http://dx.doi.org/10.4055/cios.2015.7.1.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Khosla, Sundeep, and B. Lawrence Riggs. "Treatment Options for Osteoporosis." Mayo Clinic Proceedings 70, no. 10 (1995): 978–82. http://dx.doi.org/10.4065/70.10.978.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

OʼDriscoll, Shawn W. "Elbow Arthritis: Treatment Options." Journal of the American Academy of Orthopaedic Surgeons 1, no. 2 (1993): 106–16. http://dx.doi.org/10.5435/00124635-199311000-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Hak, David J., and Gregory J. Golladay. "Olecranon Fractures: Treatment Options." Journal of the American Academy of Orthopaedic Surgeons 8, no. 4 (2000): 266–75. http://dx.doi.org/10.5435/00124635-200007000-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Starostina, L. S. "Prolonged cough: treatment options." Pediatrics (Suppl Consilium Medicum), no. 1 (2015): 70–72. http://dx.doi.org/10.26442/2413-8460_2016.1.70-72.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Astrakhantseva, M. M., A. I. Myasoutov, L. E. Breusenko, R. I. Shalina, and O. A. Latyshkevich. "Pregnancy loss. Treatment options." Voprosy ginekologii, akušerstva i perinatologii 20, no. 2 (2021): 75–84. http://dx.doi.org/10.20953/1726-1678-2021-2-75-84.

Full text
Abstract:
Objective. To justify the selection of the most effective gestagen with an optimal safety profile in the treatment of patients with pregnancy loss. Patients and methods. A retrospective study of 93 records of patients with recurrent pregnancy loss (RPL) who were prescribed gestagens was made. The first group included 49 patients taking dydrogesterone; the second – 44 patients who received micronized progesterone (19 – orally/subgroup 2a/ and 25 – intravaginally/subgroup 2b/). In order to assess the effectiveness of therapy, prolongation of pregnancy up to 22 weeks was the study’s primary endpo
APA, Harvard, Vancouver, ISO, and other styles
30

Weekes, Lynn M., Ken K. Ho, and J. Paul Seale. "Treatment Options in Acromegaly." PharmacoEconomics 10, no. 5 (1996): 453–59. http://dx.doi.org/10.2165/00019053-199610050-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

&NA;. "Postmenopausal osteoporosis: treatment options." Inpharma Weekly &NA;, no. 1342 (2002): 2. http://dx.doi.org/10.2165/00128413-200213420-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Walling, Hobart W., and Brian L. Swick. "Treatment Options for Hyperhidrosis." American Journal of Clinical Dermatology 12, no. 5 (2011): 285–95. http://dx.doi.org/10.2165/11587870-000000000-00000.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Sherwood, IAnand. "Fluorosis varied treatment options." Journal of Conservative Dentistry 13, no. 1 (2010): 47. http://dx.doi.org/10.4103/0972-0707.62631.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Granet, David B., William Christian, Cintia F. Gomi, Lydia Banuelos, and Erika Castro. "Treatment Options for Anisohyperopia." Journal of Pediatric Ophthalmology and Strabismus 43, no. 4 (2006): 207–11. http://dx.doi.org/10.3928/01913913-20060701-01.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Familiari, Pietro, Santi Greco, Ance Volkanovska, et al. "Achalasia: current treatment options." Expert Review of Gastroenterology & Hepatology 9, no. 8 (2015): 1101–14. http://dx.doi.org/10.1586/17474124.2015.1052407.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Karthaus, Meinolf, and Oliver A. Cornely. "Treatment options in candidaemia." Mycoses 50, s1 (2007): 44–49. http://dx.doi.org/10.1111/j.1439-0507.2007.01379.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Hoogerwerf, Willemijntje A., and Pankaj J. Pasricha. "Achalasia: Treatment Options Revisited." Canadian Journal of Gastroenterology 14, no. 5 (2000): 406–9. http://dx.doi.org/10.1155/2000/595349.

Full text
Abstract:
The aim of all current forms of treatment of achalasia is to enable the patient to eat without disabling symptoms such as dysphagia, regurgitation, coughing or choking. Historically, this has been accomplished by mechanical disruption of the lower esophageal sphincter fibres, either by means of pneumatic dilation (PD) or by open surgical myotomy. The addition of laparoscopic myotomy and botulinum toxin (BTX) injection to the therapeutic armamentarium has triggered a recent series of reviews to determine the optimal therapeutic approach. Both PD and BTX have excellent short term (less than thre
APA, Harvard, Vancouver, ISO, and other styles
38

L.N, Sunil Kumar, Pradnya Nagmode, Varsha Tambe, Sumeet Gonmode, and Fareedi Mukram Ali. "MIDLINE DIASTEMA: TREATMENT OPTIONS." Journal of Evolution of medical and Dental Sciences 1, no. 6 (2012): 1267–72. http://dx.doi.org/10.14260/jemds/206.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Martin Liberal, Juan, Ian Judson, and Charlotte Benson. "Treatment options for leiomyosarcoma." Expert Opinion on Orphan Drugs 1, no. 5 (2013): 413–22. http://dx.doi.org/10.1517/21678707.2013.783769.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Mayer, Geert, Claudio LA Bassetti, and Yves Dauvilliers. "Treatment options in narcolepsy." Expert Opinion on Orphan Drugs 1, no. 12 (2013): 987–99. http://dx.doi.org/10.1517/21678707.2013.854701.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Goodrich, L. R., and A. J. Nixon. "Treatment options for osteomyelitis." Equine Veterinary Education 16, no. 5 (2010): 267–80. http://dx.doi.org/10.1111/j.2042-3292.2004.tb00310.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

King, Brent R. "Treatment Options for Sinusitis." Emergency Medicine News 25, no. 3 (2003): 12. http://dx.doi.org/10.1097/00132981-200303000-00012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Gwiazda, Jane. "Treatment Options for Myopia." Optometry and Vision Science 86, no. 6 (2009): 624–28. http://dx.doi.org/10.1097/opx.0b013e3181a6a225.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Butt, W. E. "AURICULAR HAEMATOMA—TREATMENT OPTIONS." ANZ Journal of Surgery 57, no. 6 (1987): 391–92. http://dx.doi.org/10.1111/j.1445-2197.1987.tb01382.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Bashir, H., and J. Jankovic. "Treatment options for chorea." Expert Review of Neurotherapeutics 18, no. 1 (2017): 51–63. http://dx.doi.org/10.1080/14737175.2018.1403899.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

DUNN, MARIA L., ELIZABETH B. COCKERLINE, and MITCHELL R. RICE. "TREATMENT OPTIONS FOR PSORIASIS." AJN, American Journal of Nursing 88, no. 8 (1988): 1081–93. http://dx.doi.org/10.1097/00000446-198808000-00015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

&NA;. "Treatment options for HBV." Inpharma Weekly &NA;, no. 814 (1991): 6. http://dx.doi.org/10.2165/00128413-199108140-00013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Willers, Henning, and Thomas F. DeLaney. "Dermatofibrosarcoma protuberans: treatment options." Current Opinion in Orthopaedics 15, no. 6 (2004): 447–51. http://dx.doi.org/10.1097/01.bco.0000145094.73384.0c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Hutman, Sheila. "Diagnostic and Treatment Options." AIDS Patient Care 5, no. 6 (1991): 282–85. http://dx.doi.org/10.1089/apc.1991.5.282.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Harvey, Bill. "Dry eye treatment options." Optician 266, no. 6872 (2022): 36–37. http://dx.doi.org/10.12968/opti.2022.266.6872.36.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!